AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Menopause and Osteoporosis.

OB GYN News

| September 01, 2001 | COPYRIGHT 2001 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Climara (estradiol transdermal system) is now indicated for the prevention of postmenopausal ...

Related articles from newspapers, magazines, journals, and more
Mylan Announces Final Approval for Additional Strengths of Estradiol...
Press release article from: PR Newswire July 25, 2006 700+ words
...Application for Estradiol Transdermal Systems, 0.0375 mg/day and 0...supplemental ANDA for Estradiol Transdermal Systems, 0.0375 mg/day and 0...the launch of Estradiol Transdermal Systems, 0.0375 mg/day and 0...
Smallest Estrogen Replacement Patch in the World Now Available in U.S....
Press release article from: PR Newswire August 20, 2002 700+ words
...0.075 and 0.1 mg/day), offering women...with Vivelle(R)* (estradiol transdermal system) and placebo...Vivelle-Dot(R) (estradiol transdermal system) is indicated...Vivelle-Dot 0.025 mg/day is indicated for...
Vivelle-Dot(R) (estradiol transdermal system) Now Approved in New, Low Dose for...
Press release article from: PR Newswire May 20, 2002 700+ words
...0.05, 0.075 and 0.1 mg/day) are currently available...newest and lowest dose 0.025 mg/day is expected to first...0.05, 0.075 and 0.1 mg/day). Applied two times...events with Vivelle(R)* (estradiol transdermal system) and placebo, respectively...
Vivelle(R) (Estradiol Transdermal System) Receives Indication for Osteoporosis...
Press release article from: PR Newswire August 17, 2000 700+ words
...05, 0.075 and 0.1 mg/day). A new low dose of Vivelle, 0.025 mg/day, is expected to be...in late 2000. The 0.025 mg/day dosage strength is...adverse events with Vivelle (estradiol transdermal system) and placebo, respectively...
Patching up vasomotor problems.(NEW PRODUCTS)(Mylan Laboratories estradiol...
Magazine article from: Long-Term Care Interface January 1, 2007 700+ words
...in Pittsburgh, received FDA approval for estradiol transdermal systems, 0.0375 mg/day and 0.06 mg/day, indicated for the treatment of moderate...025-, 0.05-, 0.075-, and 0.1-mg/day doses. For further information, visit...
New doses of Climara.(Products)(estradiol transdermal system patches)(Brief...
Magazine article from: Family Practice News September 1, 2003 700+ words
Climara (estradiol transdermal system) patches are approved in 0.0375 mg and 0.06 mg doses for the relief of symptoms following a hysterectomy or during menopause. For more information, contact Berlex Laboratories Inc., 888-237-5394, www.cleafiyclimara.com.
Mylan Announces First Approval for Estradiol Transdermal System.
Press release article from: Business Wire February 29, 2000 700+ words
...to receive approval from the U.S. Food and Drug Administration to manufacture and market Estradiol Transdermal System 0.1 mg/day, and 0.05 mg/day (Once-a-Week Formulation). These patches are the generic equivalent to Climara...
Norelgestromin/ethinyl estradiol transdermal system--ortho evra--ortho...
Magazine article from: Internal Medicine Alert Elliott, William T. Chan, James December 29, 2001 700+ words
...clinical trials due to this reaction. Greater increases in total cholesterol (15.8 mg/dL vs 8.1 mg/dL; P < 0.001) and triglyceride (9.7 mg/dL vs 0.9 mg/dL; P = 0.008) were observed with the patch compared to an oral...
PRESS RELEASE: Low-dose Climara (estradiol transdermal system) approved for...
News wire article from: Chemical Business Newsbase April 17, 2001 700+ words
...indication for Climara. Climara 0.025 mg/day has been recommended by the FDA as...AG, Germany. Low-dose Climara 0.025 mg/day is the only ERT available that provides...individual oestrogen needs. Climara 0.025 mg/day is also indicated for the relief of...
Estradiol transdermal system (Menostar).(Pharmacology Update)
Magazine article from: Internal Medicine Alert Elliott, William T. Chan, James August 29, 2004 700+ words
...APPROVED A LOW DOSE ESTRADIOL transdermal patch for prevention...intact uterus. This estradiol transdermal system is manufactured...Berlex. Indications The estradiol transdermal system is indicated...
For more facts and information, see all results

Source: HighBeam Research, Menopause and Osteoporosis.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA